Journal of Pharmacological Sciences (Jan 2011)

Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection

  • Yasu-Taka Azuma,
  • Yukiko Matsuo,
  • Hidemitsu Nakajima,
  • George D. Yancopoulos,
  • David M. Valenzuela,
  • Andrew J. Murphy,
  • Margaret Karow,
  • Tadayoshi Takeuchi

Journal volume & issue
Vol. 115, no. 2
pp. 105 – 111

Abstract

Read online

The cytokine, interleukin (IL)-19, is a member of the IL-10 family that includes IL-20, IL-22, IL-24, and IL-26. Recent studies have shown that IL-19 is produced by keratinocytes, epithelial cells, macrophages, and B-cells. Little is known about the exact biological role of IL-19 in immunological regulation, although there is an increasing body of data demonstrating that IL-19 is associated with the development of Th2 responses and the pathogenesis of psoriasis. In this review, I shall attempt to discuss current knowledge about the role of IL-19 on macrophages and the potential role in inflammatory bowel disease. Keywords:: interleukin-19, inflammatory bowel disease (IBD), colonic inflammation, macrophages, cytokine